Team:Imperial College London/M2

From 2009.igem.org

(Difference between revisions)
Line 37: Line 37:
<tr><td width="0%"></td>
<tr><td width="0%"></td>
-
<td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/M2/EncapsulationRationale"><b>Acid Protection</b></a></center></td>
+
<td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/M2/EncapsulationRationalle"><b>Acid Protection</b></a></center></td>
-
<td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/M2/Modelling"><b>Modelling</b></a></center></td>
+
<td width="20%"><center><a href="/Team:Imperial_College_London/M2/FreezeDrying"><b>Freeze Drying</b></a></center></td>
<td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/M2/Genetic"><b>Genetic Circuit</b></a></center></td>
<td width="20%"><center><a href="https://2009.igem.org/Team:Imperial_College_London/M2/Genetic"><b>Genetic Circuit</b></a></center></td>

Revision as of 09:42, 7 October 2009




II09 Thumb m2.pngModule 2 - Encapsulsation Overview

II09 TimelineM2.png


Aside from aiding in pill manufacture, encapsulation (Module 2) allows the safe passage of polypetides through the stomach into the intestine. The encapsulation process involves the production of a physical barrier, acid resistance proteins and the preservative trehalose. Without encapsulation, our polypeptides would be denatured and degraded by stomach acid and digestive proteases respectively.




  About proteolysis.


Our solution represents a fusion between probiotic treatment & polypeptide encapsulation